Association Between Permanent Non-Valvular Atrial Fibrillation with Microalbuminuria and C-Reactive Protein
DOI:
https://doi.org/10.31661/gmj.v10i.2106Keywords:
Non-Valvular Atrial Fibrillation; Microalbuminuria; C-Reactive ProteinAbstract
Background: An understanding of atrial fibrillation (AF) mechanisms, as the most common cardiac arrhythmia, is essential for primary and secondary prevention. Some studies indicated an association between microalbuminuria and C-reactive protein (CRP) protein, with the incidence and prevalence of AF. This study aimed to investigate the relationship between permanent non-valvular AF with microalbuminuria and reactive protein C. Materials and Methods: In this case-control study, 40 permanent non-valvular AF patients and 40 non-AF patients (control group) were studied. Demographic data and measurements of albumin, urine creatinine, CRP, and microalbuminuria were recorded and compared between the two groups. Results: In patients with permanent non-valvular atrial fibrillation, CRP level (P<0.001) and microalbuminuria (P=0.012) were significantly higher than the control group. Also, in patients with permanent non-valvular AF, the CRP positive (P = 0.014) and microalbuminuria (P = 0.003) were significantly higher than controls. The results showed that elevated chance of permanent non-valvular AF with abnormal CRP was 4.25 (odds ratio [OR]= 4.25, 95% confidence interval [CI]: 1.18-1.28; P= 0.026), and with microalbuminuria was 6.54 (OR= 6.54, 95% CI: 1.65-25.89; P=0.007). Conclusion: An elevated CRP level and microalbuminuria were significantly associated with permanent non-valvular atrial fibrillation. A longitudinal study is necessary. [GMJ.2021;10:e2106]
References
Galea R, Cardillo MT, Caroli A, Marini MG, Sonnino C, Narducci ML, et al. Inflammation and C-reactive protein in atrial fibrillation: cause or effect? Texas Heart Institute Journal 2014; 41(5): 461-8. https://doi.org/10.14503/THIJ-13-3466PMid:25425976 PMCid:PMC4189345 Sarıkaya S, Åžahin S, Akyol L, Börekçi E, Keser Y, AltunkaÅŸ F, Karaman K. Is there any relationship between RDW levels and atrial fibrillation in hypertensive patient?. African Health sciences 2014; 1(1): 267-274. https://doi.org/10.4314/ahs.v14i1.41PMid:26060490 PMCid:PMC4449072 Kannie WB, Benjamin Ej. Status of epidemiology of atrial fibrillasion. Med Clin North Am 2008; 92(2): 17-40. https://doi.org/10.1016/j.mcna.2007.09.002PMid:18060995 PMCid:PMC2245891 Vardas pE,Mavrakis HE. Atrial fibrillation:a symptom treated as a disease?Hellenic J Cardiol 2006; 47(2): 191-193. Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2014; 11(7): 1102-8. https://doi.org/10.1016/j.hrthm.2014.04.003PMid:24709288 Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82(8): 2-9. https://doi.org/10.1016/S0002-9149(98)00583-9 Dernellis J, Panaretou M. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol 2006; 97(2): 245-8. https://doi.org/10.1016/j.amjcard.2005.08.027PMid:16442371 Böhm M, Thoenes M, Neuberger HR, Gräber S, Reil JC, Bramlage P, et al. Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur Heart J 2009; 30(11): 1364-71. https://doi.org/10.1093/eurheartj/ehp124PMid:19383737 Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19(8): 1992-7. https://doi.org/10.1161/01.ATV.19.8.1992PMid:10446083 Gurses KM, Yalcin MU, Kocyigit D, Evranos B, Ates AH, Yorgun H, et al. Red blood cell distribution width predicts outcome of cryoballoon-based atrial fibrillation ablation. J Interv Card Electrophysiol 2015;42(1):51-8. https://doi.org/10.1007/s10840-014-9959-yPMid:25510648 McManus DD, Corteville DC, Shlipak MG, Whooley MA, Ix JH. Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). Am J Cardiol 2009; 104(11): 1551-5. https://doi.org/10.1016/j.amjcard.2009.07.026PMid:19932791 PMCid:PMC2796571 Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60(2): 2263-70. https://doi.org/10.1016/j.jacc.2012.04.063PMid:23194937 Patel P, Dokainish H, Tsai P, Lakkis N. UpÂdate on the Association of Inflammation and Atrial Fi brillation. Journal of cardiovascular electrophysiology 2010; 21(9): 1064-1070. https://doi.org/10.1111/j.1540-8167.2010.01774.xPMid:20455973 Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.circulation 2001;104(3): 2886-91. https://doi.org/10.1161/hc4901.101760PMid:11739301 Asselbergs FW, van den Berg MP, Diercks GF, van Gilst WH, van Veldhuisen DJ. C-reactive protein and microalbuminuria are associated with atrial fibrillation. Int J Cardiol 2005; 98(1): 73-7. https://doi.org/10.1016/j.ijcard.2003.12.028PMid:15676170 Molnar AO, Eddeen AB, Ducharme R,Garg AX, et al.Association of Proteinuria andIncident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function. J Am Heart Assoc.2017; 6(4): 5685. https://doi.org/10.1161/JAHA.117.005685PMid:28684642 PMCid:PMC5586292 Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27(1): 512-518. https://doi.org/10.1093/eurheartj/ehi668PMid:16311236 McManus D, Corteville D, Shlipak MG, Whooley M, Masd J. Relation of Kidney Function and Albuminuria with Atrial Fibrillation (From the Heart and Soul Study). Am J Cardiol 2009; 104(11): 1551-1555. https://doi.org/10.1016/j.amjcard.2009.07.026PMid:19932791 PMCid:PMC2796571 Marott SC, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjærg-Hansen A, et al. Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?: A Mendelian Randomization of 47,000 Individuals From the General Population. Journal of the American College of Cardiology 2010; 56(10): 789-95. https://doi.org/10.1016/j.jacc.2010.02.066PMid:20797493 Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J 1972; 34(2): 520-5. https://doi.org/10.1136/hrt.34.5.520PMid:5031645 PMCid:PMC486968 Frustaci A, Cristina C, Fulvio B, Emanuela M, Matteo A, Attilio M. Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 1997; 96(2): 1180-4. https://doi.org/10.1161/01.CIR.96.4.1180PMid:9286947 Gür AK, Aykaç MC, ÅžiÅŸli M. The effects of serum CRP level on postoperative atrial fibrillation in patients who had coronary bypass surgery. East J Med 2018; 23(4): 284-288. https://doi.org/10.5505/ejm.2018.92053 Naoyuki S, Naokazu H, Takashi H, Shigeru A, Takuya Y, Yukinori M, Kenkichi M. C-reactive Protein and Atrial Fibrillation. Jpn Heart J 2004; 45(3): 441-445. https://doi.org/10.1536/jhj.45.441PMid:15240964 Luft FC. Angiotensin, inflammation, hypertension, and cardiovascular disease. Curr Hypertens Rep 2001; 3(1): 61-67. https://doi.org/10.1007/s11906-001-0082-yPMid:11177710
